grants_govRFA-AI-27-014
Open
Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Radiological/Nuclear or Chemical Threats (U01 Clinical Trial Not Allowed)
- Response deadline
- Oct 9, 2028 Due in 767 days
- Date posted
- Sep 1, 2026
- Source
- Open notice
Description
The purpose of this notice of funding opportunity (NOFO) is to support research that advances understanding of the natural history of radiation or chemical exposures; develops relevant injury models; identifies and validates diagnostic tools, biomarkers, or triage technologies; and supports the development of effective medical countermeasures (MCMs) to mitigate or treat acute and/or delayed injuries resulting from radiological/nuclear or chemical public health emergencies.
Classifications
- NAICS93.233
Documents (1)
- RFA-AI-27-014-Full-Announcement.htmltext/html;charset=UTF-8132 KBNot yet available
Contacts
Similar contracts
- NIH Research Project Grant (Parent R01 Clinical Trial Required)Due Jan 7, 2028
- NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional)Due Apr 28, 2027
- Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Required)Due May 7, 2027
- Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)Due Feb 8, 2028
- NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food SpecimensDue Apr 1, 2027
- Animal Food Regulatory Program Standards Implementation Development and Maintenance, with Mutual Reliance Initiatives Clinical Trials Not AllowedDue Apr 1, 2027